Dr. Pravin Chaturvedi is the Chairman of the Scientific Advisory Board for Napo Pharmaceuticals and also serves as a Director and CEO for IndUS and Oceanyx Pharmaceuticals. He is an experienced drug developer and biotech entrepreneur. Previously he was the CEO of Pivot and Scion Pharmaceuticals; and was the Head of Lead Evaluation at Vertex and was in Product Development groups at Alkermes and Parke-Davis/Warner-Lambert (Pfizer). Over his career, he has participated in the successful development of several new drugs for the treatment of CNS, viral and gastrointestinal disorders. In addition to the boards of IndUS and Oceanyx, Dr. Chaturvedi also serves on the boards of Cellanyx, FuelEd Schools and Sindu Research Laboratories. He has previously served on the boards of Pivot, Scion, Bach Pharma, PRADAN USA, Sindu Pharmaceuticals and TiE Boston. He also serves on several advisory boards including Enlivity and is as an adjunct faculty member at Georgetown Medical School. He holds a Ph.D. in Pharmaceutical Sciences from West Virginia University.